68Ga-戊曲酯 PET/CT 在肾上腺微结节原发性醛固酮增多症患者亚型诊断中的临床价值
该研究前瞻性纳入经肾上腺 CT 发现肾上腺微结节(直径小于 1 cm)的原发性醛固酮增多症(PA)患者行 68Ga-pentixafor PET/CT,以手术病理及术后随访或肾上腺静脉采血(AVS)结果分组。104 例可分析患者中,视觉分析识别适合手术患者的敏感度、特异度和准确率分别为 90.2%、72.7% 和 86.5%,均显著高于肾上腺 CT 的 73.1%、53.8% 和 68.3%。结论认为 68Ga-pentixafor PET/CT 在分类诊断上表现出较好的诊断准确率,似乎优于肾上腺 CT,并提示在预测术后疗效方面较 AVS 有一定潜力,但这些观察需在更大队列中进一步研究和验证。
要点
- 对肾上腺微结节 PA 患者,68Ga-pentixafor PET/CT 视觉分析识别适合手术者的敏感度 90.2%、特异度 72.7%、准确率 86.5%。
- 上述指标显著高于肾上腺 CT 的敏感度 73.1%、特异度 53.8%、准确率 68.3%。
- 在 17 例接受肾上腺切除术者中,PET/CT 与手术结局的一致性为 82.4%,AVS 为 68.86%。
核心结论
- 在肾上腺微结节的 PA 患者中,68Ga-pentixafor PET/CT 在分类诊断上表现出较好的诊断准确率,似乎优于肾上腺 CT。
- 与 AVS 相比,68Ga-pentixafor PET/CT 在预测术后疗效方面也提示有一定潜力,但这些观察需在更大队列中进一步研究和验证。
研究设计与样本
- 前瞻性纳入经肾上腺 CT 发现肾上腺微结节(直径小于 1 cm)的 PA 患者行 68Ga-pentixafor PET/CT。
- 根据手术病理和术后随访或 AVS 结果将患者分为适合手术组与不适合手术组,患者管理由多学科团队讨论。
- 共 123 例 PA 伴肾上腺微结节患者接受 68Ga-pentixafor PET/CT 检查,其中 104 例接受手术或成功 AVS 者纳入分析(48 ± 10 岁)。
主要发现
- 68Ga-pentixafor PET/CT 视觉分析识别适合手术患者的敏感度、特异度和准确率分别为 90.2%、72.7% 和 86.5%,显著高于肾上腺 CT 的 73.1%、53.8% 和 68.3%,且在不同 CT 形态或年龄亚组中结果一致。
- 36 例同时接受 AVS 和 68Ga-pentixafor PET/CT 的患者中,两种检查的一致率为 66.7%。
- 在 17 例接受肾上腺切除术的患者中,PET/CT 与手术结局的一致性为 82.4%,AVS 为 68.86%,PET/CT 显著更高。
- 研究纳入的 183 个肾上腺微结节中,92 个适合手术治疗的病灶的半定量诊断阈值为:SUVmax 至少 4.55、病灶与肝脏 SUV 比值至少 2.17、病灶与正常肾上腺 SUV 比值至少 1.90。
- 所有患者均从手术切除 68Ga-pentixafor 高摄取微病灶中获益。
关键数值与推荐
- 68Ga-pentixafor PET/CT 视觉分析识别适合手术患者的敏感度 90.2%、特异度 72.7%、准确率 86.5%。
- 肾上腺 CT 识别适合手术患者的敏感度 73.1%、特异度 53.8%、准确率 68.3%。
- 适合手术的 92 个肾上腺微结节半定量阈值为 SUVmax 至少 4.55、病灶与肝脏 SUV 比值至少 2.17、病灶与正常肾上腺 SUV 比值至少 1.90。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出这些观察需在更大队列中进一步研究和验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Our objective was to investigate the clinical value of 68Ga-pentixafor PET/CT in subtype diagnosis of primary aldosteronism (PA) patients with adrenal micronodules less than 1 cm in diameter and compare it with the routine clinical methods. Methods: We used prospective enrollment of PA patients with adrenal micronodules identified by adrenal CT scans to undergo 68Ga-pentixafor PET/CT. Patients were divided into surgically eligible and ineligible groups based on surgical pathology and postoperative follow-up or adrenal venous sampling (AVS) results. Patient management was discussed by a multidisciplinary team. The semiquantitative parameters of PET/CT included SUVmax for adrenal lesion and SUV ratios for lesion to liver and lesion to normal adrenal gland. Results: In total, 123 PA patients with adrenal micronodules were examined using 68Ga-pentixafor PET/CT, and 104 patients who underwent surgery or successful AVS were included in the analysis (48 ± 10 y old). The sensitivity, specificity, and accuracy of visual analysis using 68Ga-pentixafor PET/CT to identify surgically eligible patients were 90.2%, 72.7%, and 86.5%, respectively, which were significantly higher than those of adrenal CT (73.1%, 53.8%, and 68.3%, respectively) and yielded consistent results in different CT morphologic or age subgroups. In 36 patients who had both AVS and 68Ga-pentixafor PET/CT, the tests showed a 66.7% concordance rate. However, PET/CT was significantly more concordant with surgical outcomes than was AVS in 17 patients who underwent adrenalectomy (82.4% vs. 68.86%). Among the 183 adrenal micronodules included in the study, the semiquantitative diagnostic thresholds for 92 lesions eligible for surgical treatment were an SUVmax of at least 4.55, an SUV ratio of at least 2.17 for lesion to liver, and an SUV ratio of at least 1.90 for lesion to normal adrenal gland. All patients benefited from surgical removal of 68Ga-pentixafor-avid microlesions. Conclusion: In PA patients with adrenal micronodules, 68Ga-pentixafor PET/CT demonstrated promising diagnostic accuracy in classification and appeared to perform better than adrenal CT. Furthermore, there was also a suggestion of some potential in predicting postoperative efficacy compared with AVS, although these observations require further investigation and verification in larger cohorts.
引用
- Ding J, Li X, Liu S, et al. Clinical Value of 68Ga-Pentixafor PET/CT in Subtype Diagnosis of Primary Aldosteronism Patients with Adrenal Micronodules. J Nucl Med. 2024. PMID: 38050127. doi:10.2967/jnumed.123.266061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。